Home >
A Polymer-based
scaffold
For controlled delivery
of therapies
along the GI tract
Epitomee’s groundbreaking platform technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials
Mode of Use
The device is swallowed
with 2 cups of water
with 2 cups of water
The outer capsule
dissolves when exposed
to target site pH
dissolves when exposed
to target site pH
The hydrogel particles
absorb surrounding fluid
and swell, expanding the
device scaffolds to their
final shape
absorb surrounding fluid
and swell, expanding the
device scaffolds to their
final shape
The devices each have their
unique expansion-
disintegration profile and
perform their therapeutic purpose for a pre-
determined period of time
unique expansion-
disintegration profile and
perform their therapeutic purpose for a pre-
determined period of time
After the elapsed deployment
period, the scaffolds
disintegrate and flow freely
down the GI tract
period, the scaffolds
disintegrate and flow freely
down the GI tract
